Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
Clinical trial NCT06608342 · RECRUITING
Trial details
- NCT number
- NCT06608342
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2026-05-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.